- Home
- MHUA vs PMN Comparison
MHUA vs PMN Comparison
Compare MHUA & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MHUA
- PMN
- Stock Information
- Founded
- MHUA 1990
- PMN 2004
- Country
- MHUA China
- PMN Canada
- Employees
- MHUA N/A
- PMN N/A
- Industry
- MHUA Medical Specialities
- PMN Pharmaceuticals and Biotechnology
- Sector
- MHUA Health Care
- PMN Health Care
- Exchange
- MHUA Nasdaq
- PMN Nasdaq
- Market Cap
- MHUA 19.6M
- PMN 16.0M
- IPO Year
- MHUA 2022
- PMN N/A
- Fundamental
- Price
- MHUA $0.47
- PMN $0.40
- Analyst Decision
- MHUA
- PMN Strong Buy
- Analyst Count
- MHUA 0
- PMN 2
- Target Price
- MHUA N/A
- PMN $4.50
- AVG Volume (30 Days)
- MHUA 123.7K
- PMN 63.7K
- Earning Date
- MHUA 04-25-2025
- PMN 08-07-2025
- Dividend Yield
- MHUA N/A
- PMN N/A
- EPS Growth
- MHUA N/A
- PMN N/A
- EPS
- MHUA 0.40
- PMN N/A
- Revenue
- MHUA $96,909,642.00
- PMN N/A
- Revenue This Year
- MHUA N/A
- PMN N/A
- Revenue Next Year
- MHUA N/A
- PMN N/A
- P/E Ratio
- MHUA $1.22
- PMN N/A
- Revenue Growth
- MHUA N/A
- PMN N/A
- 52 Week Low
- MHUA $0.25
- PMN $0.38
- 52 Week High
- MHUA $1.47
- PMN $2.37
- Technical
- Relative Strength Index (RSI)
- MHUA 57.94
- PMN 32.23
- Support Level
- MHUA $0.36
- PMN $0.48
- Resistance Level
- MHUA $0.51
- PMN $0.50
- Average True Range (ATR)
- MHUA 0.05
- PMN 0.03
- MACD
- MHUA 0.00
- PMN -0.01
- Stochastic Oscillator
- MHUA 75.68
- PMN 18.75
About MHUA Meihua International Medical Technologies Co. Ltd.
Meihua International Medical Technologies Co Ltd is engaged in providing disposable medical devices. It serves hospitals, pharmacies, medical institutions, and medical equipment companies. Its product offerings include a Disposable Medical mask, Disposable ID Bracelet, Disposable Artificial Anal bag, Disposable Catheter, and Electonic pump among others.
About PMN ProMIS Neurosciences Inc. (ON)
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.